ask="7.40"
ask_size="100"
average_daily_volume="23415"
bid="4.90"
bid_size="100"
book_value="1.81"
change="+0.06"
change_from_200_day_moving_average="-0.51"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-4.42"
change_From_52_week_low="0.39"
change_in_percent="+1.00%"
close="6.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.86"
ebitda="-9.95M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8775000"
high="6.20"
high_52_weeks="10.51"
last_trade_date="3/13/2017"
last_trade_price="6.09"
last_trade_size="100"
last_trade_time="3:59pm"
low="5.97"
low_52_weeks="5.70"
market_capitalization="80.89M"
moving_average_200_day="6.60"
moving_average_50_day="6.26"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="19.33"
open="6.02"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.77%"
percent_change_from_50_day_moving_average="-2.79%"
percent_change_from_52_week_high="-42.06%"
percent_change_from_52_week_low="+6.84%"
previous_close="6.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.34"
price_per_sales="64.03"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="10.25"
stock_exchange="NCM"
symbol="ORMP"
volume="14310"
weeks_range_52="5.70 - 10.51"
